MedPath

Running nose manage with steam inhalation.

Phase 2
Not yet recruiting
Conditions
Chronic pansinusitis,
Registration Number
CTRI/2025/04/084448
Lead Sponsor
Dr Madiha Anjum
Brief Summary

A Randomized Comparative Clinical Trial- Assessing the efficacy of Medicated and Non-Medicated inkibaba (steam Inhalation) with atus (Errhine therapy) in the Management of waram tajawif al anaf muzmin (Chronic Sinusitis). Chronic sinusitis is characterised by nasal symptoms of sinus inflammation lasting for more than 12 weeks. It is 2 types: with nasal polyps and without polyps. The Infectious Disease of America (IDSA) states that the symptoms of sinusitis is out of any three symptoms include purulent discharge, nasal congestion or nasal blockage, facial pain or pressure, hyposmia, and anosmia. In unani waram tajawif al anf muzmin (WTA), it is caused by external cold, sudda (blockage), and ufunat (infection); hence it is considered a waram tajawif al anaf muzmin. In this study, an attempt is made to evaluate the effectiveness of inkibab  (Medicated steam inhalation ) with atus (Errhine therapy ) in the management of waram tajawif al anaf muzmin. The main aim of the study was to compare the effectiveness of two unani intervention, inkibab (steam inhalation) with medicated herbal decoction containing gul e babuna, nakhuna, tukhm shibbit, satar (6gm each) to be boiled in four cups of water (1000ml) with a closed lid for a few minutes and other with only plain water stem inhalation followed by atus (errhine therapy)  with the drug of irsa (iris ensata) in the management of warm e tajawif anaf muzmin. The trial is conducted for comparative analysis of medicated steam inhalation and only plain water inhalation, followed by errhine therapy (snuff) in the management of chronic sinusitis. Therapy will be given for 5 weeks at OPD and IPD  of PG Department of IBT, Arignar Anna Government Hospital of Indian Medicine attached with Government Unani Medical College (GUMC), Chennai-600 106. The patients will be asked to have a regular follow-up in the OPD weekly. Every week, the clinical assessment will be recorded in the prescribed pro forma. The laboratory investigation will be done before and after treatment and will be received in the prescribed format.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
38
Inclusion Criteria

Age 18-60 years Both gender Patient Present with the complaints of chronic sinusitis Willingness to participate in the study.

Exclusion Criteria

Below 18 year and above 60 year Mentally retarded person A patient who had congenital abnormality of the nasal cavity Not willing to give concern.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness of two unani intervention therapy assessed by using VAS scale for facial Pain and VAS score for improving the overall severity of symptoms (subjective parameter).3 WEEKS
Secondary Outcome Measures
NameTimeMethod
SNOT 22 Quality of life scale35 weeks

Trial Locations

Locations (1)

Arignar Anna Hospital

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna Hospital
🇮🇳Chennai, TAMIL NADU, India
Dr Madiha Anjum
Principal investigator
7708421967
drmadihaanjum98@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.